Transdermal absorption preparation
    5.
    发明申请
    Transdermal absorption preparation 审中-公开
    透皮吸收制剂

    公开(公告)号:US20050255149A1

    公开(公告)日:2005-11-17

    申请号:US10516944

    申请日:2003-07-02

    摘要: A transdermal absorption promotion composition comprising the following components (a), (b), and (c) and a transdermal absorption preparation comprising the following components (a), (b), (c), and (d) are disclosed. (a) propylene glycol (b) a polyol fatty acid ester (c) lauromacrogol (d) a drug component The transdermal absorption promotion composition and transdermal absorption preparation not only exhibit an excellent transdermal absorption promotion effect, but also exhibit superior skin-permeability, even if a drug having a relatively high lipophilic property and poor transdermal absorbability is used, exhibit a favorable feeling of use, and are safe and stable.

    摘要翻译: 公开了包含以下组分(a),(b)和(c)的透皮吸收促进组合物和包含以下组分(a),(b),(c)和(d)的透皮吸收制剂。 (a)丙二醇(b)多元醇脂肪酸酯(c)多羟考摩尔(d)药物成分透皮吸收促进组合物和透皮吸收制剂不仅表现出优异的透皮吸收促进作用,而且还表现出优异的皮肤渗透性, 即使使用亲脂性比较高,透皮吸收性差的药物,使用感好,安全稳定。

    Aqueous suspension for nasal drops
    6.
    发明申请
    Aqueous suspension for nasal drops 审中-公开
    滴鼻水悬浮液

    公开(公告)号:US20070190081A1

    公开(公告)日:2007-08-16

    申请号:US11245252

    申请日:2005-10-07

    IPC分类号: A61K31/573 A61K9/00

    摘要: It is intended to provide an aqueous suspension for nasal drops, which is easy to prepare, with maintaining superior long-term stability, good redispersibility and high retainability after the intranasal administration, as well as having good after feel. The aqueous suspension for nasal drops comprising containing the following (a), (b), (c), (d), (e) and (f): (a) A compound represented by the following formula (1) wherein R is hydroxyl or cyclohexylcarbonyloxy, or solvate thereof; (b) crystalline cellulose-carmellose sodium 0.1-5% by weight; (c) hydroxypropylcellulose 0.05-1% by weight; (d) nonionic surfactant 0.001-0.2% by weight; (e) moistening agent; and (f) buffering agent.

    摘要翻译: 本发明提供一种易于制备的鼻滴水性悬浮液,其具有优异的长期稳定性,良好的再分散性和鼻内给药后的高保留性,以及良好的感觉。 含有下述(a),(b),(c),(d),(e)和(f))的滴鼻水性悬浮液:(a)由下式(1) 羟基或环己基羰氧基或其溶剂合物; (b)结晶纤维素 - 羧甲纤维素钠0.1-5重量%; (c)0.05-1重量%的羟丙基纤维素; (d)0.001-0.2重量%的非离子表面活性剂; (e)润湿剂; 和(f)缓冲剂。

    Sustained release suppository
    7.
    发明授权
    Sustained release suppository 失效
    持续释放栓剂

    公开(公告)号:US5500221A

    公开(公告)日:1996-03-19

    申请号:US215970

    申请日:1994-03-18

    IPC分类号: A61K9/02 A61K9/14 A61K9/64

    摘要: The present invention relates to a sustained-release suppository preparation characterized by comprising an acidic drug or a salt thereof which can be absorbed by rectal administration and an acidic compound or a pH buffering agent. The sustained-release suppository preparation of the present invention exhibits no rapid increase in blood concentration immediately after the administration and maintains its action for a long period of time. Thus, it is safer and exhibits a better therapeutic effect.

    摘要翻译: 本发明涉及缓释栓剂制剂,其特征在于包含可通过直肠给药吸收的酸性药物或其盐,以及酸性化合物或pH缓冲剂。 本发明的持续释放栓剂制剂在施用后立即显示出血液浓度的迅速增加,并且长时间保持其作用。 因此,它更安全,具有更好的治疗效果。